TELABio_Logo.png
TELA Bio to Participate in Canaccord Genuity’s 41st Annual Growth Conference
August 03, 2021 07:00 ET | TELA Bio, Inc.
MALVERN, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement...
TELABio_Logo.png
TELA Bio to Announce Second Quarter 2021 Financial Results
July 28, 2021 07:00 ET | TELA Bio, Inc.
MALVERN, Pa., July 28, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement...
TELABio_Logo.png
NHS Surgeon First in Europe to Implant TELA Bio's OviTex® LPR Reinforced Tissue Matrix
July 21, 2021 08:28 ET | TELA Bio, Inc.
MALVERN, Pa., July 21, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue...
TELABio_Logo.png
TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference
June 14, 2021 07:00 ET | TELA Bio, Inc.
MALVERN, Pa., June 14, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement...
TELABio_Logo.png
TELA Bio Announces Changes to its Board of Directors
June 02, 2021 07:00 ET | TELA Bio, Inc.
MALVERN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement...
TELABio_Logo.png
TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs
May 25, 2021 07:00 ET | TELA Bio, Inc.
MALVERN, Pa., May 25, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement...
TELABio_Logo.png
TELA Bio to Participate in Upcoming Investor Conferences
May 21, 2021 07:00 ET | TELA Bio, Inc.
MALVERN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement...
TELABio_Logo.png
TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias
May 19, 2021 07:00 ET | TELA Bio, Inc.
MALVERN, Pa., May 19, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement...
TELABio_Logo.png
TELA Bio Announces First Quarter 2021 Financial Results
May 13, 2021 16:02 ET | TELA Bio, Inc.
MALVERN, Pa., May 13, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing, and marketing innovative tissue...
TELABio_Logo.png
TELA Bio to Announce First Quarter 2021 Financial Results
April 29, 2021 16:00 ET | TELA Bio, Inc.
MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue...